What hypnosis does to the brain
By scanning the brains of subjects while they were hypnotized, researchers at the School of Medicine were able to see the neural changes associated with hypnosis.
Pediatric pulmonologist Nanci Yuan dies
Yuan led the development of the Pediatric Sleep Center at Lucile Packard Children’s Hospital Stanford and advanced care for children whose breathing was impaired by severe muscular disease.
Antibodies could counter atherosclerosis
A biological drug could be used to combat cardiovascular disease by targeting not mere risk factors such as high cholesterol or high blood pressure, but the actual lesions bearing direct responsibility: atherosclerotic plaques.
Hormone therapy: No effect on mental skills
Hormone therapy for postmenopausal women has been controversial, with some studies suggesting benefits and others not. Now, a study finds the treatment’s effect on women’s mental skills is negligible.
Coaxing stem cells to quickly specialize
A new study shows that combining positive and negative signals can quickly and efficiently steer stem cells down complex developmental pathways to become specialized tissues that could be used in the clinic.
Vision partially restored in mice
Broken links between retinal ganglion cells and target structures throughout the brain spell permanent vision loss. But in a new study, these long-distance connections — and partial vision — were restored.
Surgeries a risk for chronic opioid use
A new study reinforces the need for surgeons and physicians to monitor patients' use of painkillers following surgery and use alternative methods of pain control whenever possible.
Test could greatly reduce antibiotic use
A simple blood test in development could accurately identify which patients need antibiotics, Stanford researchers say.
Cancer institute earns comprehensive status
The designation is recognition of the Stanford Cancer Institute’s robust and integrated programs encompassing laboratory research, clinical care and community outreach and education.
Treating rare blood cancers
Patients with a group of cancers known as advanced systemic mastocytosis have few treatment options. A drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.